IPSEN (OTCMKTS:IPSEY) Stock Price Passes Above 200 Day Moving Average – Here’s Why

IPSEN (OTCMKTS:IPSEY)’s stock price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $41.56 and traded as high as $48.76. IPSEN shares last traded at $48.76, with a volume of 109 shares.

Analysts Set New Price Targets

Separately, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of IPSEN in a report on Thursday. One analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold”.

IPSEN Stock Performance

The business’s 50 day simple moving average is $47.22 and its 200-day simple moving average is $41.56.

IPSEN Company Profile

Ipsen is a global biopharmaceutical company headquartered in Boulogne-Billancourt, France. Founded in 1929, the company focuses on specialty care areas including oncology, neuroscience and rare diseases. Ipsen develops, manufactures and commercializes innovative medicines that address critical unmet medical needs, offering a diverse portfolio of therapies for both adult and pediatric patient populations.

The company’s oncology franchise includes treatments for prostate, renal and hepatocellular carcinomas, with key products such as Cabometyx (cabozantinib) and Decapeptyl (triptorelin).